Skip to content

EPS (Diluted) at other companies

Merck & Co. logo
Merck & Co.MRK
-$1.72-186%
Zoetis logo
ZoetisZTS
$1.42+6.0%
Neogen logo
NeogenNEOG
-$0.08-60.0%
Balchem logo
BalchemBCPC
$1.25+10.6%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
-$13.43-4,377%
Amgen logo
AmgenAMGN
$3.34+4.4%

Other financials

Income statement

See full
Revenue$383.5M+10.3%
Gross profit$125.7M+20.2%
Operating income$44.7M+33.2%
Net income$24.0M+15.1%

Balance sheet

See full
Cash & equivalents$54.9M-9.0%
Total debt$32.3M+27.8%
Total equity$361.8M+36.0%
Total assets$1.4B+9.7%

Cash flow

See full
Operating cash flow$16.2M-62.4%
CapEx$15.3M+97.7%
Free cash flow$890.0K-97.5%

Valuation

See full
Market cap$1.27B+159%
Enterprise value$1.25B+167%
P/E13.4×-2.1×
P/S0.9×+0.4×

Profitability

See full
Gross margin32.5%+0.9pp
Operating margin12%+4.0pp
Net margin6.3%+3.7pp
FCF margin0.9%-3.3pp

Returns & leverage

See full
Return on equity30.3%+18.5pp
Debt / equity0.1×0.0×
Current ratio3.2×+0.3×

Where this comes from

Reported directly by Phibro Animal Health in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phibro Animal Health's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phibro Animal Health's EPS (diluted)?
Phibro Animal Health (PAHC) reported EPS (diluted) of $0.59 in Q1 2026.
How has Phibro Animal Health's EPS (diluted) changed year-over-year?
Phibro Animal Health's EPS (diluted) increased by 15.7% year-over-year, from $0.51 to $0.59.
What is the long-term trend for Phibro Animal Health's EPS (diluted)?
Over 4 years (2021 to 2025), Phibro Animal Health's EPS (diluted) has grown at a -2.9% compound annual growth rate (CAGR), from $1.34 to $1.19.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.